NCT05987254

Brief Summary

Severe pain associated with fractured hip often results in difficulty during positioning for spinal anesthesia (SA). Among many regional analgesic techniques, the fascia iliaca compartment block (FICB) is popular among anesthesiologists to provide immediate as well as postoperative analgesia in hip fractures. Recently, the pericapsular nerve group (PENG) block has been proposed to provide effective analgesia in hip fracture patients. However, comparative studies between PENG and FICB are lacking.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

August 10, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2024

Completed
Last Updated

July 31, 2024

Status Verified

July 1, 2024

Enrollment Period

8 months

First QC Date

August 4, 2023

Last Update Submit

July 30, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • NRS

    In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10, that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.

    30 minute postoperative

  • The ease of spinal positioning (EOSP)

    The ease of spinal positioning (EOSP) was assessed on the scale of 0-3 (0 = unable to position, 1 = patient had abnormal posturing due to pain and required support for positioning, 2 = mild discomfort but does not require support for positioning, 3 = optimal condition where the patient was able to position himself without pain)

    Thirty minutes after the blocks

Secondary Outcomes (1)

  • amount of tramadol used

    24 hours postoperatively

Study Arms (2)

FICB group

ACTIVE COMPARATOR

received ultrasound guided suprainguinal fascia iliaca block

Procedure: suprainguinal fascia iliaca block

PENG group

ACTIVE COMPARATOR

received ultrasound guided pericapsular nerve group block

Procedure: pericapsular nerve group block

Interventions

ultrasound guided suprainguinal fascia iliaca block

FICB group

ultrasound guided pericapsular nerve group block

PENG group

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years and above with hip fracture with persistent pain and scheduled for surgery under spinal anesthesia (SA)

You may not qualify if:

  • any contraindications to SA or peripheral nerve blocks, history of ischaemic heart disease, patients on opioids for chronic pain and patients with significant cognitive impairment. Patients who had no pain while sitting by themselves (resting pain less than 4 on NRS) for SA without any support were also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Haney Baumey

Banhā, 13518, Egypt

Location

Facualty of Pharmacy, Al Azhar University

Cairo, 11765, Egypt

Location

Neveen Kohaf

Tanta, 11865, Egypt

Location

MeSH Terms

Conditions

Hip Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Clinical Pharmacy

Study Record Dates

First Submitted

August 4, 2023

First Posted

August 14, 2023

Study Start

August 10, 2023

Primary Completion

March 30, 2024

Study Completion

March 30, 2024

Last Updated

July 31, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

data will be shared upon resealable request from the principal investigator

Shared Documents
STUDY PROTOCOL, SAP

Locations